Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients

@article{Sambri2017PediatricST,
  title={Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients},
  author={Andrea Sambri and Giuseppe Bianchi and Ilaria Cucurnia and Marco Gambarotti and Davide Maria Donati},
  journal={European Journal of Orthopaedic Surgery & Traumatology},
  year={2017},
  volume={28},
  pages={1-7}
}
Soft tissue sarcomas (STS) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial. We retrospectively evaluated 97 patients younger than 15 years old affected by limb soft tissue sarcomas. All cases were histologically revised, and tumor grade was assessed according to the FNLCC system. Thirty-two were rhabdomyosarcoma (RMS) and 65 non-rhabdomyosarcoma (NRMSTS); among these, 40 (61.5%) were grade 3… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Soft tissue sarcomas ( STS ) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial .
Soft tissue sarcomas ( STS ) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial .
soft tissueIs normal tissue origin of diseaseSarcoma
Soft tissue sarcomas ( STS ) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial .
Pediatric soft tissue sarcoma of the limbs : clinical outcome of 97 patients .
We retrospectively evaluated 97 patients younger than 15 years old affected by limb soft tissue sarcomas .
Soft tissue sarcomas ( STS ) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial .
Soft tissue sarcomas ( STS ) of the extremities in children are a heterogeneous group of tumors with a very different prognosis for which optimal treatment remains controversial .
All Topics